Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MOLN compared with BNTC: revenue, margins and what each company keeps, and the suppliers and customers both name
MOLN
Molecular Partners AG
Change
Mkt cap
Revenue
Revenue
BNTC
Benitec Biopharma Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
MOLN
Molecular Partners AG
vs
BNTC
Benitec Biopharma Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only MOLN
1
—
Orano Med
unlisted
supplier
Shared
0
No shared counterparties.
Only BNTC
2
—
Australian government
unlisted
supplier
—
Axovant Therapeutics
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
MOLN
Molecular Partners AG
Change
3.40
▼
−5.03%
Mkt cap
$144.5M
Revenue
—
BNTC
Benitec Biopharma Inc.
Change
8.45
▼
−3.36%
Regular session
Nov 2 '26
Mkt cap
$304.9M
Revenue
$7,000
Q4 FY23
vs
Compare
Regular session
Nov 2 '26
MOLN
Molecular Partners AG
vs
BNTC
Benitec Biopharma Inc.
3.40
▼
−5.03%
Price
8.45
▼
−3.36%
$144.5M
Mkt cap
$304.9M
—
Revenue
$7,000
Q4 FY23
Change
Change
MOLN
3.40
▼
−5.03%
vs
BNTC
8.45
▼
−3.36%
Regular session
Nov 2 '26